BioPharma Credit is lending $100m to Trasus Pharmaceuticals. BioPharma Credit Investments V will lend an additional $100m alongside this. Based in the US, Tarsus is a publicly traded biopharmaceutical company with a current market capitalisation of about $1.2bn (Ticker: TARS – NASDAQ). Tarsus currently markets XDEMVY® (lotilaner ophthalmic solution), a treatment for Demodex blepharitis. XDEMVY® […]
US Solar Fund is planning a fixed-price tender offer at $0.764 per share (equivalent to the 31 December 2023 NAV of $0.78 per share, less 2% for the costs of administering the tender offer). Shareholders may choose to tender for sale some or all of their shares, subject to an upper limit of $19m being […]
Martin Currie Global Portfolio managed to beat the return on the MSCI All Country World Index over the 12 months ended 31 January 2024, returning 11.2% to the index’s 10.9%. A stable discount (the result of its zero dividend discount mechanism) meant that the return to shareholders was 11.1%. The company declared dividends totaling 4.2p […]
In QuotedData’s morning briefing 24 April 2024: Apax Global Alpha (APAX) is investing about €8m (through its investment in Apax Digital II) into IANS, “a leading provider of tech-enabled research and advisory services in the information security industry”. The transaction is expected to close in Q2 2024. Octopus Renewables Infrastructure (ORIT) has signed a power […]
Ian Lance, co-manager of Temple Bar, had this to say: We note the statement from the Board of IDS confirming that on 9 April 2024 it received a preliminary and conditional non-binding proposal from EP Group regarding a possible cash offer for the entire issued and to be issued share capital of International Distribution Services […]
There is no announcement to the stock exchange on this yet, but Sky, the FT and other news outlets have a story that Blackstone is proposing to buy Hipgnosis Songs Fund for $1.24 in cash (about 99.6p per share), trumping the $1.16 per share offer from Chorus that was announced on Thursday. $1.24 is an […]
HydrogenOne Capital Growth has published results for the year ended 31 December 2023. We’ll be publishing a note on these shortly, so here is a quick summary: The NAV increased by 5.8% from £125.4m at 31 December 2022 to £132.7m at 31 December 2023 due to valuation uplifts in multiple portfolio companies. The NAV per […]
HydrogenOne Capital Growth has announced a change to the corporate structure of its invetsment in HH2E (the German developer of hydrogen production plants). HH2E is backed by HydrogenOne and Foresight Group (including JLEN Environmental Assets). They have investments in HH2E itself, and separately into project-specific special purpose vehicles (SPVs) managed by HH2E. HydrogenOne has invested […]
JZ Capital Partners wants to invest up to about US$20.5m into the Secondary Fund managed by an affiliate of JZCP’s manager. The money would be used to help the Secondary Fund make an investment into a newly incorporated company – Follow-on Flex Pack – that will be a related company of, and incorporated in a […]
Alliance Trust says that Willis Tower Watson has appointed a new stock picker for its multi-manager global equity portfolio. ARGA Investment Management replaces Jupiter Asset Management, following Ben Whitmore’s decision to leave Jupiter later this year and set up his own business. Craig Baker, WTW’s chief investment officer and chair of the investment committee, said: […]